Physician profile
Lori Caputi
NPI 1336251511
$3,802.24
in general payments reported to CMS, 2019-2025
24 companies · $835 in 2025
The $835 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $333 · 2021: $126 · 2022: $657 · 2023: $597 · 2024: $432 · 2025: $835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,863.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $700.27 | 2022-2025 | Infuse, Miebo, Xiidra |
| Alcon Vision LLC | $577.26 | 2019-2025 | Precision7, Hydrus Microstent |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $444.06 | 2019-2021 | |
| Sight Sciences, INC. | $312.51 | 2022-2024 | Omni Surgical System |
| Dompe US, INC. | $236.36 | 2024-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $192.38 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $179.78 | 2019-2023 | Cequa |
| Tarsus Pharmaceuticals, INC. | $155.45 | 2025 | Xdemvy |
| Coopervision INC. | $151.52 | 2022-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Shire North American Group INC | $148.73 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $95.39 | 2023-2024 | Acuvue |
| Abbvie INC. | $89.49 | 2023-2024 | Lumigan, Vuity |
| Glaukos Corporation | $86.81 | 2024 | Idose |
| Eyevance Pharmaceuticals LLC | $78.97 | 2019-2021 | |
| Biotissue Holdings INC. | $69.61 | 2021-2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $66.14 | 2020 | |
| Ocular Therapeutix, INC. | $52.65 | 2024-2025 | Dextenza |
| Notal Vision, INC. | $37.98 | 2025 | Foresee Home |
| Aerie Pharmaceuticals, INC. | $34.49 | 2019-2020 | |
| Plexus Optix, INC. | $24.05 | 2021 | |
| Abb Con-Cise Optical Group LLC | $21.00 | 2020 | |
| Oyster Point Pharma, INC. | $20.08 | 2023 | Tyrvaya |
| Lkc Technologies, INC. | $14.44 | 2023 | |
| Rxsight INC | $12.82 | 2023 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Caputi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.